Walk through survey report: exposure to estrogens at G.D. Searle and Company, Skokie, Illinois, report no. IWS-085-17.
Zaebst-D; Tanaka-S; Haring-M; Baum-E
NIOSH 1980 Jan; :1-10
A walk through survey was made at G.D. Searle and Company, Skokie, Illinois for the purpose of evaluating potential exposure to estrogenic substances as part of the NIOSH study of occupational exposures to estrogens. This facility contained 12 major building and associated facilities comprising approximately 723,000 square feet. Oral contraceptives, primarily Enovid, were produced here from 1958 through 1979. The total number of employees who ever worked in the production areas was about 2000 as of 1979. The records needed to conduct a mortality or a reproductive study were only available for the period since 1966. Secondly, only since 1974 have any women worked in areas of potentially high exposure. At the time of the survey, this site was not manufacturing any estrogenic or oral contraceptive drugs. Even though the site had produced oral contraceptives on a large scale since 1958, the authors do not recommend it as a suitable site for inclusion in the larger study.
NIOSH-Author; NIOSH-Survey; Field-Study; IWS-085-17; Region-5; Pharmaceuticals; Laboratory-workers; Pharmaceutical-industry; Estrogenic-hormones
Industry Wide; Field Studies
NTIS Accession No.
Industry-wide Studies Branch, Division of Surveillance, Hazard Evaluations and Field Studies, NIOSH, Cincinnati, Ohio, Report No. IWS-085-17, 10 pages